Last reviewed · How we verify
Ultracet Tablets
Ultracet combines tramadol (an opioid agonist and monoamine reuptake inhibitor) with acetaminophen to provide analgesia through dual pathways of pain relief.
Ultracet combines tramadol (an opioid agonist and monoamine reuptake inhibitor) with acetaminophen to provide analgesia through dual pathways of pain relief. Used for Moderate acute pain in adults.
At a glance
| Generic name | Ultracet Tablets |
|---|---|
| Also known as | Reference drug |
| Sponsor | Pfizer |
| Drug class | Opioid analgesic combination |
| Target | Mu-opioid receptor; norepinephrine and serotonin transporters; COX enzymes |
| Modality | Small molecule |
| Therapeutic area | Pain Management |
| Phase | FDA-approved |
Mechanism of action
Tramadol acts as a weak mu-opioid receptor agonist and inhibits the reuptake of norepinephrine and serotonin, enhancing descending pain inhibitory pathways. Acetaminophen works through poorly understood mechanisms involving central COX inhibition and endocannabinoid system modulation. Together, these agents provide synergistic pain relief for moderate acute pain.
Approved indications
- Moderate acute pain in adults
Common side effects
- Dizziness
- Nausea
- Constipation
- Headache
- Somnolence
- Pruritus
- Vomiting
Key clinical trials
- Paracetamol-Tramadol and Paracetamol-caffeine Versus Placebo in the Emergency Discharge Treatment of Renal Colic (PHASE2)
- Perioperative Polmacoxib Reduce Opioid Consumption for Post Operative Pain After Rotator Cuff Tear. (NA)
- Tramadol-paracetamol Combination in Treatment of Patients Undergoing Spinal Surgery (PHASE4)
- Efficacy and Safety of Fixed-dose Combination of Etoricoxib/Tramadol vs Acetaminophen/Tramadol for Acute Low Back Pain (PHASE3)
- Assessment of the Pharmacokinetics of a Sustained Release Formulation of a Tramadol/Acetaminophen Combination (PHASE1)
- Bioequivalence Study of Tramadol Hydrochloride /Paracetamol Tablets Versus Ultracet Tablets (PHASE4)
- Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions (PHASE1)
- Effect of Combined Use of Naloxone and Tramacet on Postop Analgesia in Elderly Patients Having Joint Replacement Surgery (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |